195 related articles for article (PubMed ID: 11606368)
1. Hypoxia-inducible factor-1alpha is an intrinsic marker for hypoxia in cervical cancer xenografts.
Vukovic V; Haugland HK; Nicklee T; Morrison AJ; Hedley DW
Cancer Res; 2001 Oct; 61(20):7394-8. PubMed ID: 11606368
[TBL] [Abstract][Full Text] [Related]
2. A noninvasive approach for assessing tumor hypoxia in xenografts: developing a urinary marker for hypoxia.
Nelson DW; Cao H; Zhu Y; Sunar-Reeder B; Choi CY; Faix JD; Brown JM; Koong AC; Giaccia AJ; Le QT
Cancer Res; 2005 Jul; 65(14):6151-8. PubMed ID: 16024616
[TBL] [Abstract][Full Text] [Related]
3. Lack of correlation between expression of HIF-1alpha protein and oxygenation status in identical tissue areas of squamous cell carcinomas of the uterine cervix.
Mayer A; Wree A; Höckel M; Leo C; Pilch H; Vaupel P
Cancer Res; 2004 Aug; 64(16):5876-81. PubMed ID: 15313932
[TBL] [Abstract][Full Text] [Related]
4. HER-2/neu overexpression increases the viable hypoxic cell population within solid tumors without causing changes in tumor vascularization.
Dragowska WH; Warburton C; Yapp DT; Minchinton AI; Hu Y; Waterhouse DN; Gelmon K; Skov K; Woo J; Masin D; Huxham LA; Kyle AH; Bally MB
Mol Cancer Res; 2004 Nov; 2(11):606-19. PubMed ID: 15561777
[TBL] [Abstract][Full Text] [Related]
5. Prognostic impact of HIF-1alpha expression in patients with definitive radiotherapy for cervical cancer.
Dellas K; Bache M; Pigorsch SU; Taubert H; Kappler M; Holzapfel D; Zorn E; Holzhausen HJ; Haensgen G
Strahlenther Onkol; 2008 Mar; 184(3):169-74. PubMed ID: 18330514
[TBL] [Abstract][Full Text] [Related]
6. Dysregulation of hypoxia inducible factor-1alpha in head and neck squamous cell carcinoma cell lines correlates with invasive potential.
Cohen NA; Lai SY; Ziober AF; Ziober BL
Laryngoscope; 2004 Mar; 114(3):418-23. PubMed ID: 15091212
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia-inducible factor-1alpha promotes nonhypoxia-mediated proliferation in colon cancer cells and xenografts.
Dang DT; Chen F; Gardner LB; Cummins JM; Rago C; Bunz F; Kantsevoy SV; Dang LH
Cancer Res; 2006 Feb; 66(3):1684-936. PubMed ID: 16452228
[TBL] [Abstract][Full Text] [Related]
8. Expression of hypoxic-inducible factor 1alpha predicts metastasis-free survival after radiation therapy alone in stage IIIB cervical squamous cell carcinoma.
Ishikawa H; Sakurai H; Hasegawa M; Mitsuhashi N; Takahashi M; Masuda N; Nakajima M; Kitamoto Y; Saitoh J; Nakano T
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):513-21. PubMed ID: 15380586
[TBL] [Abstract][Full Text] [Related]
9. Glucose requirement for hypoxic accumulation of hypoxia-inducible factor-1alpha (HIF-1alpha).
Vordermark D; Kraft P; Katzer A; Bölling T; Willner J; Flentje M
Cancer Lett; 2005 Dec; 230(1):122-33. PubMed ID: 16253768
[TBL] [Abstract][Full Text] [Related]
10. Analysis of hypoxia-inducible factor-1alpha accumulation and cell cycle in geldanamycin-treated human cervical carcinoma cells by laser scanning cytometry.
Schwock J; Geddie WR; Hedley DW
Cytometry A; 2005 Dec; 68(2):59-70. PubMed ID: 16228978
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of hypoxia-inducible factor 1alpha indicates diminished response to radiotherapy and unfavorable prognosis in patients receiving radical radiotherapy for cervical cancer.
Bachtiary B; Schindl M; Pötter R; Dreier B; Knocke TH; Hainfellner JA; Horvat R; Birner P
Clin Cancer Res; 2003 Jun; 9(6):2234-40. PubMed ID: 12796391
[TBL] [Abstract][Full Text] [Related]
12. Expression of hypoxia-inducible factor (HIF)-1alpha is associated with vascular endothelial growth factor expression and tumour angiogenesis in human oesophageal squamous cell carcinoma.
Kimura S; Kitadai Y; Tanaka S; Kuwai T; Hihara J; Yoshida K; Toge T; Chayama K
Eur J Cancer; 2004 Aug; 40(12):1904-12. PubMed ID: 15288294
[TBL] [Abstract][Full Text] [Related]
13. EF5 binding and clinical outcome in human soft tissue sarcomas.
Evans SM; Fraker D; Hahn SM; Gleason K; Jenkins WT; Jenkins K; Hwang WT; Zhang P; Mick R; Koch CJ
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(3):922-7. PubMed ID: 16458778
[TBL] [Abstract][Full Text] [Related]
14. [Impact of RNA interference targeting hypoxia-inducible factor-1alpha on chemosensitivity in esophageal squamous cell carcinoma cells under hypoxia].
Wu XA; Sun Y; Fan QX; Wang LX; Wang RL; Zhang L
Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(37):2640-4. PubMed ID: 18162154
[TBL] [Abstract][Full Text] [Related]
15. Over expression of hypoxia-inducible factor-1alpha in renal and bladder cancer cells increases tumorigenic potency.
Kondo Y; Hamada J; Kobayashi C; Nakamura R; Suzuki Y; Kimata R; Nishimura T; Kitagawa T; Kunimoto M; Imura N; Hara S
J Urol; 2005 May; 173(5):1762-6. PubMed ID: 15821583
[TBL] [Abstract][Full Text] [Related]
16. Suppression of the hypoxia-inducible factor-1 response in cervical carcinoma xenografts by proteasome inhibitors.
Birle DC; Hedley DW
Cancer Res; 2007 Feb; 67(4):1735-43. PubMed ID: 17308115
[TBL] [Abstract][Full Text] [Related]
17. 2-methoxyestradiol inhibits hypoxia-inducible factor 1alpha, tumor growth, and angiogenesis and augments paclitaxel efficacy in head and neck squamous cell carcinoma.
Ricker JL; Chen Z; Yang XP; Pribluda VS; Swartz GM; Van Waes C
Clin Cancer Res; 2004 Dec; 10(24):8665-73. PubMed ID: 15623651
[TBL] [Abstract][Full Text] [Related]
18. [Expression of hypoxia-inducible factor-1alpha and vessel endothelial growth factor in esophageal squamous cell carcinoma and clinico-pathological significance thereof].
Yu ZT; Zhao HF; Shang XB
Zhonghua Yi Xue Za Zhi; 2008 Sep; 88(35):2465-9. PubMed ID: 19080625
[TBL] [Abstract][Full Text] [Related]
19. Detection of hypoxia in human squamous cell carcinoma by EF5 binding.
Evans SM; Hahn S; Pook DR; Jenkins WT; Chalian AA; Zhang P; Stevens C; Weber R; Weinstein G; Benjamin I; Mirza N; Morgan M; Rubin S; McKenna WG; Lord EM; Koch CJ
Cancer Res; 2000 Apr; 60(7):2018-24. PubMed ID: 10766193
[TBL] [Abstract][Full Text] [Related]
20. Significance of HIF-1-active cells in angiogenesis and radioresistance.
Harada H; Kizaka-Kondoh S; Li G; Itasaka S; Shibuya K; Inoue M; Hiraoka M
Oncogene; 2007 Nov; 26(54):7508-16. PubMed ID: 17563752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
